Join us at the 11th Global
Pharmaceutical Quality Summit 2026
Join us at the 11th Global
Pharmaceutical Quality Summit 2026
Experience Leucine AI .
Powered Pharma Operations

Transform Your Pharma Operations with AI-Powered Intelligence. Experience how Leucine's integrated platform brings together manufacturing, quality, and laboratory operations in one digital ecosystem. Schedule a personalized demo to see how our AI solutions can optimize your processes, ensure compliance, and drive operational excellence.

See How AI Transforms Your Shop Floor Operations.
Experience firsthand how Leucine's 10x MES digitalizes batch records, streamlines production, and provides real-time monitoring of your manufacturing operations. Schedule a personalized demo to discover how our AI-powered platform can enhance your productivity while maintaining compliance.

Experience AI-Driven Quality Management in Action.
See how Leucine's 10x QMS automates compliance workflows, streamlines change control, and ensures regulatory adherence. Schedule a demo to learn how our AI-powered platform can help you manage quality processes more efficiently while reducing compliance risks.

Discover Smart Laboratory Operations Management.
Watch how Leucine's 10x LES orchestrates your lab operations, automates documentation, and ensures data integrity. Schedule a demo to see how our AI-powered platform can accelerate your testing processes while maintaining audit-readiness.

Optimize your manufacturing processes with paperless operations
Strengthen quality management and regulatory compliance
Accelerate laboratory operations and testing workflows

Connect with a Leucine Expert

Schedule a 30-Minute Product Demo with Expert Q&A

Sub System /
Equipment Qualification
Equipment Qualification
View Detailed Analysis

Analytics Overview

82
Form 483s Issued
13
483s converted to WL
97
Total Observation
Form 483s Issued
+74 from last period

Analytics Overview

Form 483 Conversion Rate by Year
Form 483s Issued (Yearly)

Recent Form 483s & Warning Letters

View all 483’s
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Dec 2025
JKR Pharmacy Ventures, LLC dba Doc Lane's Veterinary Pharmacy
Drugs
12 Dec 2025
Dr. Reddy's Laboratories Limited
Drugs
21 Nov 2025
Shilpa Medicare Limited
Drugs
14 Oct 2025
UBI Pharma Inc.
Drugs
23 Sep 2025
Hikma Pharmaceuticals USA Inc.
Drugs

Top Investigators

Investigator Name
Form 483 Count
Warning Letter Count
José E Melendez
6
0
Yvins Dezan
4
0
Demario L Walls
4
0
Pratik S Upadhyay
4
1
David Carlson
3
0
TITLE/ COMPANY Issue Date Status Details
Procedures designed to prevent microbiological contamination of drug products
JKR Pharmacy Ventures, LLC dba Doc Lane's Veterinary Pharmacy
19 Dec 2025 Normal Justification: The observation refers to non-qualified sterilizers, indicating equipment qualification deficiencies.
Excerpt: Sterilization cycles used have not been initially validated or periodically verified.
View Details
Control procedures are not established which validate the performance of those manufacturing processes
Dr. Reddy's Laboratories Limited
12 Dec 2025 Normal Justification: Equipment Qualification was bypassed after equipment replacement. Qualification ensures that equipment performs correctly.
Excerpt: Your Head of Production stated that the working principles for (b) (4) are same thus requalification is not needed.
View Details
The separate or defined areas and control systems necessary to prevent contamination
Shilpa Medicare Limited
21 Nov 2025 Normal Justification: The lack of equipment qualification after modifying critical gaskets links directly to Equipment Qualification processes.
Excerpt: Equipment # SMLJ 051 gasket was modified without documented risk assessment or qualification.
View Details
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use
UBI Pharma Inc.
14 Oct 2025 Normal Justification: The linkage is evident as the observation centers on the lack of qualification for AQL testing and defect management.
Excerpt: Review of the qualification report... confirmed that the was not qualified for the defect categories.
View Details
Seamless unit diffusions expert parallel formulations prefacing situational outcome plans entrainable logically
Hikma Pharmaceuticals USA Inc.
23 Sep 2025 Normal Justification: The interchangeable nature of facilities suggests equipment use without full qualification for process integrity.
Excerpt: Interchangeable underwriting facilities.
View Details

Prepare Better for FDA Audits with FDA Tracker

Get Real-time Insights: FDA 483s & Warning letters.
Uncover Trends: FDA Investigator profiles & Observations.
Stay Compliant: Manage risks proactively.

Equipment Qualification

Explore essential insights on batch release processes to enhance compliance and quality. Dive into our article for practical guidance and best practices.

Equipment Qualification

Overview

82
Form 483s Issued
13
483s converted to WL
97
Total Observation
Form 483s Issued
+74 from last period

Recent Form 483s & Warning Letters

Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
19 Dec 2025
JKR Pharmacy Ventures, LLC dba Doc Lane's Veterinary Pharmacy
Drugs
12 Dec 2025
Dr. Reddy's Laboratories Limited
Drugs
21 Nov 2025
Shilpa Medicare Limited
Drugs
14 Oct 2025
UBI Pharma Inc.
Drugs
23 Sep 2025
Hikma Pharmaceuticals USA Inc.
Drugs

Top FDA Investigators

Investigator Name
Form 483 Count
Warning Letter Count
José E Melendez
6
0
Yvins Dezan
4
0
Demario L Walls
4
0
Pratik S Upadhyay
4
1
David Carlson
3
0

Key Observations

TITLE/ COMPANY Issue Date Status Details
Procedures designed to prevent microbiological contamination of drug products
JKR Pharmacy Ventures, LLC dba Doc Lane's Veterinary Pharmacy
19 Dec 2025 Normal Justification: The observation refers to non-qualified sterilizers, indicating equipment qualification deficiencies.
Excerpt: Sterilization cycles used have not been initially validated or periodically verified.
View Details
Control procedures are not established which validate the performance of those manufacturing processes
Dr. Reddy's Laboratories Limited
12 Dec 2025 Normal Justification: Equipment Qualification was bypassed after equipment replacement. Qualification ensures that equipment performs correctly.
Excerpt: Your Head of Production stated that the working principles for (b) (4) are same thus requalification is not needed.
View Details
The separate or defined areas and control systems necessary to prevent contamination
Shilpa Medicare Limited
21 Nov 2025 Normal Justification: The lack of equipment qualification after modifying critical gaskets links directly to Equipment Qualification processes.
Excerpt: Equipment # SMLJ 051 gasket was modified without documented risk assessment or qualification.
View Details
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use
UBI Pharma Inc.
14 Oct 2025 Normal Justification: The linkage is evident as the observation centers on the lack of qualification for AQL testing and defect management.
Excerpt: Review of the qualification report... confirmed that the was not qualified for the defect categories.
View Details
Seamless unit diffusions expert parallel formulations prefacing situational outcome plans entrainable logically
Hikma Pharmaceuticals USA Inc.
23 Sep 2025 Normal Justification: The interchangeable nature of facilities suggests equipment use without full qualification for process integrity.
Excerpt: Interchangeable underwriting facilities.
View Details

Frequently Asked Questions

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Experience Leucine AI Powered pharma manufacturing
300+ pharma facilities worldwide use Leucine to stay compliant. Talk to one of our expert consultants at Leucine to learn how.
Related Resources

View and learn more about FDA Inspections
with our comprehensive list of resources